Deciphering the epidemic synergy of herpes simplex virus type 2 (HSV-2) on human immunodeficiency virus type 1 (HIV-1) infection among women in sub-Saharan Africa

BMC Research Notes

Volumn 5, Issue , 2012, Pages

  Ghebremichael, Musie ^a   Habtzgi, Desale ^b   Paintsil, Elijah ^c  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b UNIVERSITY OF AKRON   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN HERPESVIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

ADULT; AGE; ARTICLE; CROSS-SECTIONAL STUDY; EPIDEMIC; FEMALE; GENITAL HERPES; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MIXED INFECTION; MULTIVARIATE ANALYSIS; PREVALENCE; RISK FACTOR; STATISTICS; TANZANIA; URBAN POPULATION; VIROLOGY;

ADULT; AGE FACTORS; COINFECTION; CROSS-SECTIONAL STUDIES; EPIDEMICS; FEMALE; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; HIV INFECTIONS; HIV-1; HUMANS; MALE; MULTIVARIATE ANALYSIS; PREVALENCE; RISK FACTORS; TANZANIA; URBAN POPULATION; YOUNG ADULT;

EID: 84865301516     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-5-451     Document Type: Article

References (35)

1. An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection. Looker KJ, Garnett GP, Schmid GP, Bull World Health Organ 2008 86 10 805 812 A. 10.2471/BLT.07.046128 18949218
2. Association between human immunodeficiency virus and herpes simplex virus type 2 seropositivity among male factory workers in Zimbabwe. Gwanzura L, McFarland W, Alexander D, Burke RL, Katzenstein D, J Infect Dis 1998 177 2 481 484 10.1086/517381 9466543 (Pubitemid 28063781)
3. Recent herpes simplex virus type 2 infection and the risk of human immunodeficiency virus type 1 acquisition in India. Reynolds SJ, Risbud AR, Shepherd ME, Zenilman JM, Brookmeyer RS, Paranjape RS, Divekar AD, Gangakhedkar RR, Ghate MV, Bollinger RC, et al. J Infect Dis 2003 187 10 1513 1521 10.1086/368357 12721931 (Pubitemid 36578957)
4. Risk factors influencing HIV infection incidence in a rural African population: a nested case-control study. Todd J, Grosskurth H, Changalucha J, Obasi A, Mosha F, Balira R, Orroth K, Hugonnet S, Pujades M, Ross D, et al. J Infect Dis 2006 193 3 458 466 10.1086/499313 16388496 (Pubitemid 43122348)
5. Herpes simplex virus type 2: a key role in HIV incidence. Glynn JR, Biraro S, Weiss HA, AIDS 2009 23 12 1595 1598 10.1097/QAD.0b013e32832e15e8 19512858
6. Genital herpes simplex virus type 2 shedding is increased in HIV-infected women in Africa. Mbopi Keou FX, Gresenguet G, Mayaud P, Weiss HA, Gopal R, Brown DW, Hayes RJ, Mabey DC, Belec L, AIDS (London, England) 1999 13 4) 536 537
7. Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression. Schacker T, Zeh J, Hu H, Shaughnessy M, Corey L, J Infect Dis 2002 186 12 1718 1725 10.1086/345771 12447756 (Pubitemid 35463503)
8. The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics. Corey L, Wald A, Celum CL, Quinn TC, J Acquir Immune Defic Syndr 2004 35 5 435 445 10.1097/00126334- 200404150-00001 15021308 (Pubitemid 38420652)
9. A seroepidemiologic survey of the prevalence of herpes simplex virus type 2 infection in the United States. Johnson RE, Nahmias AJ, Magder LS, Lee FK, Brooks CA, Snowden CB, N Engl J Med 1989 321 1 7 12 10.1056/NEJM198907063210102 2543928 (Pubitemid 19170378)
10. Seroprevalence of herpes simplex virus type 2 among persons aged 14-49 years - United States. MMWR Morb Mortal Wkly Rep 2005-2008 59 15 456 459 20414188
11. Genital herpes has played a more important role than any other sexually transmitted infection in driving HIV prevalence in Africa. Abu-Raddad LJ, Magaret AS, Celum C, Wald A, Longini IM Jr, Self SG, Corey L, PLoS One 2008 3 5 2230 10.1371/journal.pone.0002230 18493617
12. Genital herpes and human immunodeficiency virus: double trouble. Celum C, Levine R, Weaver M, Wald A, Bull World Health Organ 2004 82 6 447 453 15356938 (Pubitemid 38828431)
13. How does herpes simplex virus type 2 influence human immunodeficiency virus infection and pathogenesis? Wald A, Corey L, J Infect Dis 2003 187 10 1509 1512 10.1086/374976 12721930 (Pubitemid 36578956)
14. Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. Celum C, Wald A, Lingappa JR, Magaret AS, Wang RS, Mugo N, Mujugira A, Baeten JM, Mullins JI, Hughes JP, et al. N Engl J Med 2010 362 5 427 439 10.1056/NEJMoa0904849 20089951
15. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. Wawer MJ, Gray RH, Sewankambo NK, Serwadda D, Li X, Laeyendecker O, Kiwanuka N, Kigozi G, Kiddugavu M, Lutalo T, et al. J Infect Dis 2005 191 9 1403 1409 10.1086/429411 15809897 (Pubitemid 40563350)
16. Genital shedding of herpes simplex virus-2 DNA and HIV-1 RNA and proviral DNA in HIV-1- and herpes simplex virus-2-coinfected African women. Mbopi-Keou FX, Legoff J, Gresenguet G, Si-Mohamed A, Matta M, Mayaud P, Andreoletti L, Malkin JE, Weiss H, Brown D, et al. J Acquir Immune Defic Syndr 2003 33 2 121 124 10.1097/00126334-200306010-00001 12794542 (Pubitemid 36793143)
17. Impact of suppressive herpes therapy on genital HIV-1 RNA among women taking antiretroviral therapy: a randomized controlled trial. Ouedraogo A, Nagot N, Vergne L, Konate I, Weiss HA, Defer MC, Foulongne V, Sanon A, Andonaba JB, Segondy M, et al. AIDS 2006 20 18 2305 2313 10.1097/QAD.0b013e328010238d 17117016 (Pubitemid 44789532)
18. Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial. Zuckerman RA, Lucchetti A, Whittington WL, Sanchez J, Coombs RW, Zuniga R, Magaret AS, Wald A, Corey L, Celum C, J Infect Dis 2007 196 10 1500 1508 10.1086/522523 18008230 (Pubitemid 351411987)
19. Long-term impact of acyclovir suppressive therapy on genital and plasma HIV RNA in Tanzanian women: a randomized controlled trial. Tanton C, Weiss HA, Rusizoka M, Legoff J, Changalucha J, Baisley K, Mugeye K, Everett D, Belec L, Clayton TC, et al. J Infect Dis 2010 201 9 1285 1297 10.1086/651696 20235836
20. Meta-analysis of randomized trials on the association of prophylactic acyclovir and HIV-1 viral load in individuals coinfected with herpes simplex virus-2. Ludema C, Cole SR, Poole C, Chu H, Eron JJ, AIDS 2011 25 10 1265 1269 10.1097/QAD.0b013e328347fa37 21666542
21. Acyclovir is activated into a HIV-1 reverse transcriptase inhibitor in herpesvirus-infected human tissues. Lisco A, Vanpouille C, Tchesnokov EP, Grivel JC, Biancotto A, Brichacek B, Elliott J, Fromentin E, Shattock R, Anton P, et al. Cell Host Microbe 2008 4 3 260 270 10.1016/j.chom.2008.07.008 18779052
22. A missed point in deciphering the viral synergy between herpes simplex virus and HIV. Lisco A, Vanpouille C, Margolis L, Lancet Infect Dis 2009 9 9 522 523 10.1016/S1473-3099(09)70209-9 19695487
23. Prevalence of, and risk factors for, HSV-2 antibodies in sexually transmitted disease patients, healthy pregnant females, blood donors and medical students in Tanzania and Norway. Nilsen A, Mwakagile D, Marsden H, Langeland N, Matre R, Haarr L, Epidemiol Infect 2005 133 5 915 925 10.1017/S095026880500395X 16181514 (Pubitemid 41478979)
24. Association of age at first sex with HIV-1, HSV-2, and other sexual transmitted infections among women in northern Tanzania. Ghebremichael M, Larsen U, Paintsil E, Sex Transm Dis 2009 36 9 570 576 10.1097/OLQ.0b013e3181a866b8 19707109
25. Classical latent variable models for medical research. Rabe-Hesketh S, Skrondal A, Stat Methods Med Res 2008 17 1 5 32 17855748 (Pubitemid 351359119)
26. Schabenberger O, Growing up fast: SAS 9.2 enhancements to the GLIMMIX procedure Orlando, FL: SAS Global Forum 2007
27. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis. Wald A, Link K, J Infect Dis 2002 185 1 45 52 10.1086/338231 11756980 (Pubitemid 34043015)
28. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. Freeman EE, Weiss HA, Glynn JR, Cross PL, Whitworth JA, Hayes RJ, AIDS 2006 20 1 73 83 10.1097/01.aids.0000198081.09337.a7 16327322 (Pubitemid 41818117)
29. Incident and prevalent herpes simplex virus type 2 infection increases risk of HIV acquisition among women in Uganda and Zimbabwe. Brown JM, Wald A, Hubbard A, Rungruengthanakit K, Chipato T, Rugpao S, Mmiro F, Celentano DD, Salata RS, Morrison CS, et al. AIDS 2007 21 12 1515 1523 10.1097/QAD. 0b013e3282004929 17630545 (Pubitemid 47075471)
30. Herpes simplex virus type 2 infection increases HIV incidence: a prospective study in rural Tanzania. del Mar Pujades Rodriguez M, Obasi A, Mosha F, Todd J, Brown D, Changalucha J, Mabey D, Ross D, Grosskurth H, Hayes R, AIDS 2002 16 3 451 462 10.1097/00002030-200202150-00018 11834958 (Pubitemid 34165378)
31. Correlates of plasma HIV-1 RNA viral load among HIV-1-seropositive women in Dar es Salaam, Tanzania. Kapiga SH, Bang H, Spiegelman D, Msamanga GI, Coley J, Hunter DJ, Fawzi WW, J Acquir Immune Defic Syndr 2002 30 3 316 323 12131569 (Pubitemid 34774080)
32. Evolution of recurrent herpes simplex lesions, An immunohistologic study. Cunningham AL, Turner RR, Miller AC, Para MF, Merigan TC, J Clin Invest 1985 75 1 226 233 10.1172/JCI111678 3880773 (Pubitemid 15171242)
33. Direct recovery of herpes simplex virus (HSV)-specific T lymphocyte clones from recurrent genital HSV-2 lesions. Koelle DM, Abbo H, Peck A, Ziegweid K, Corey L, J Infect Dis 1994 169 5 956 961 10.1093/infdis/169.5.956 8169426 (Pubitemid 24303211)
34. Transactivation of the HIV-1 LTR by HSV-1 immediate-early genes. Margolis DM, Rabson AB, Straus SE, Ostrove JM, Virology 1992 186 2 788 791 10.1016/0042-6822(92)90048-T 1310199
35. Prevalence of antibodies to herpes simplex virus types 1 and 2 in pregnant women, and estimated rates of infection. Ades AE, Peckham CS, Dale GE, Best JM, Jeansson S, J Epidemiol Community Health 1989 43 1 53 60 10.1136/jech.43.1.53 2556492 (Pubitemid 19076741)